8:15 am
Induced pluripotent stem cells (iPSCs) transformed stem cell biology and biomedical research. But to bring more iPSC-based therapies to patients, it is pivotal to continue addressing knowledge gaps and roadblocks. This workshop, hosted by the...
NIH Campus
12:00 am
The ITM’s parent organization NIH NCATS is accepting proposals to collaborate with its Bridging Interventional Development Gaps (BrIDGs) and Therapeutics for Rare and Neglected Diseases (TRND) program scientists. BrIDGs scientists collaborate with researchers to advance treatments for both common...
5:00 pm
The National Cancer Institute will award $400,000 per year for up to five years for projects that develop state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue...
5:00 pm
NIH’s, the ITM’s parent organization, National Institute on Aging and National Cancer Institute will fund research projects that increase our understanding of the clinical translational potential of metformin to delay aging changes or to extend healthy...
5:00 pm
This National Cancer Institute funding supports research focused on reducing health disparities in tobacco use by developing innovative tobacco prevention and control policies. The long-term goal of this FOA is to reduce health disparities in health outcomes...
5:00 pm
The NIH’s National Institute on Aging will award $40,000 per year to applications from qualified researchers to acquire training and career development experiences that close expertise gaps in data science and in drug discovery. The goal...
5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
5:00 pm
The National Institute of Mental Health will fund up to $1.75 million per year for applications for Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research. The institute seeks teams of researchers employing...
5:00 pm
This National Cancer Institute funding supports research focused on reducing health disparities in tobacco use by developing innovative tobacco prevention and control policies. The long-term goal of this FOA is to reduce health disparities in health outcomes...
5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
5:00 pm
This National Cancer Institute funding supports research focused on reducing health disparities in tobacco use by developing innovative tobacco prevention and control policies. The long-term goal of this FOA is to reduce health disparities in health outcomes...
5:00 pm
The National Institute of Mental Health will fund up to $1.75 million per year for applications for Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research. The institute seeks teams of researchers employing...
5:00 pm
This National Cancer Institute funding supports research focused on reducing health disparities in tobacco use by developing innovative tobacco prevention and control policies. The long-term goal of this FOA is to reduce health disparities in health outcomes...
5:00 pm
This National Cancer Institute funding supports research focused on reducing health disparities in tobacco use by developing innovative tobacco prevention and control policies. The long-term goal of this FOA is to reduce health disparities in health outcomes...
5:00 pm
This National Cancer Institute funding supports research focused on reducing health disparities in tobacco use by developing innovative tobacco prevention and control policies. The long-term goal of this FOA is to reduce health disparities in health outcomes...
Sep
26
Tue
Workshop on Translational Challenges of Induced Pluripotent Stem Cells (iPSC) @ NIH Campus
Sep 26 @ 8:15 am – 5:00 pm
Workshop on Translational Challenges of Induced Pluripotent Stem Cells (iPSC) @ NIH Campus | Bethesda | Maryland | United States

Induced pluripotent stem cells (iPSCs) transformed stem cell biology and biomedical research. But to bring more iPSC-based therapies to patients, it is pivotal to continue addressing knowledge gaps and roadblocks. This workshop, hosted by the ITM’s parent organization NIH NCATS, will focus on collaborative opportunities, addressing challenges, and applying best practices in translational iPSC research. Topics of interest are quality control standards, safety, experimental reproducibility, manufacturing, improved protocols, and more.

Goals for the workshop include:

  • Highlighting the biological and technological challenges of iPSCs into clinical applications and drug discovery;
  • Evaluating the field of iPSC translation and discussing critical steps for quality control, standardization, and reproducibility;
  • Discussing methods of protocol development/optimization and molecular and functional analyses; and
  • Seeking input from experts for the iPSC field.

Read More Here

Sep
30
Sat
DEADLINE: NCATS Collaborative Pre-Clinical Development Programs Proposals
Sep 30 all-day
DEADLINE: NCATS Collaborative Pre-Clinical Development Programs Proposals

The ITM’s parent organization NIH NCATS is accepting proposals to collaborate with its Bridging Interventional Development Gaps (BrIDGs) and Therapeutics for Rare and Neglected Diseases (TRND) program scientists.

BrIDGs scientists collaborate with researchers to advance treatments for both common and rare diseases into clinical testing. TRND researchers and their collaborators move new treatments through pre-clinical testing. Submit your proposal now for the opportunity to collaborate with researchers nationwide.

Learn More Here

Oct
5
Thu
DEADLINE: Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research Application
Oct 5 @ 5:00 pm
DEADLINE: Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research Application

The National Cancer Institute will award $400,000 per year for up to five years for projects that develop state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology. The projects supported by this FOA will establish and collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program.

Learn more and submit your application here.

Source: NIH

DEADLINE: Potential Effects of Metformin on Aging and Age-Related Conditions Application
Oct 5 @ 5:00 pm
DEADLINE: Potential Effects of Metformin on Aging and Age-Related Conditions Application

NIH’s, the ITM’s parent organization, National Institute on Aging and National Cancer Institute will fund research projects that increase our understanding of the clinical translational potential of metformin to delay aging changes or to extend healthy human life span.  This includes identification of specific populations particularly likely to benefit from treatment, and/or obtaining information on metformin’s effects that would be useful in identifying novel molecular targets.

Learn more and submit your application.

Source: NIH

Oct
11
Wed
DEADLINE: U.S. Tobacco Control Policies to Reduce Health Disparities Application
Oct 11 @ 5:00 pm
DEADLINE: U.S. Tobacco Control Policies to Reduce Health Disparities Application

This National Cancer Institute funding supports research focused on reducing health disparities in tobacco use by developing innovative tobacco prevention and control policies. The long-term goal of this FOA is to reduce health disparities in health outcomes in vulnerable populations by reducing diseases related to tobacco use within these groups. Budgets are not limited but must reflect the amount needed to fund the project.

Click Here to Learn More

Oct
12
Thu
DEADLINE: Research Career Enhancement Award to Advance Therapy Development for Alzheimer’s (K18) Applications
Oct 12 @ 5:00 pm
DEADLINE: Research Career Enhancement Award to Advance Therapy Development for Alzheimer's (K18) Applications

The NIH’s National Institute on Aging will award $40,000 per year to applications from qualified researchers to acquire training and career development experiences that close expertise gaps in data science and in drug discovery. The goal of the program is to allow Alzheimer’s Disease (AD) researchers to expand their expertise to become more effective in leading cross-disciplinary, translational, team-science projects in AD research.

Learn more and submit your application.

Source: National Institute on Aging

Nov
29
Wed
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application
Nov 29 @ 5:00 pm
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application

Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and NCATS wants solutions. NCATS’ (the ITM’s parent organization) spurs the development, demonstration, and dissemination of innovations across the translational science spectrum to turn discoveries from the laboratory into tangible benefits to human health. NCATS’s Clinical and Translational Science Award (CTSA) hubs, like the ITM, promote advances in translational research and training at participating institutions.

This funding opportunity funds up to $275,000 to new exploratory and developmental research projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on translational science. This grant will enable collaborative teams of investigators from at least two different CTSA institutions to address translational science questions. Collaborations that bring together approaches from different scientific disciplines are encouraged.

Learn more and submit your application here.

Source: NCATS

Mar
29
Thu
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application
Mar 29 @ 5:00 pm
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application

Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and NCATS wants solutions. NCATS’ (the ITM’s parent organization) spurs the development, demonstration, and dissemination of innovations across the translational science spectrum to turn discoveries from the laboratory into tangible benefits to human health. NCATS’s Clinical and Translational Science Award (CTSA) hubs, like the ITM, promote advances in translational research and training at participating institutions.

This funding opportunity funds up to $275,000 to new exploratory and developmental research projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on translational science. This grant will enable collaborative teams of investigators from at least two different CTSA institutions to address translational science questions. Collaborations that bring together approaches from different scientific disciplines are encouraged.

Learn more and submit your application here.

Source: NCATS

May
24
Thu
DEADLINE: Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research Application
May 24 @ 5:00 pm
DEADLINE: Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research Application

The National Institute of Mental Health will fund up to $1.75 million per year for applications for Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research. The institute seeks teams of researchers employing integrative, novel, and creative experimental approaches to address high-risk, high-impact questions in basic neuroscience or translational research with the primary objectives of: (a) advancing the state of the science in basic brain and behavior research  that will ultimately provide the foundation for understanding mental disorders; (b) supporting the integration and translation of basic and clinical neuroscience research on severe mental illnesses; and/or (c) advancing our understanding of the neurobehavioral mechanisms that begin in childhood and adolescence.

Learn more and submit your application here.

Source: NIH

Jun
13
Wed
DEADLINE: U.S. Tobacco Control Policies to Reduce Health Disparities Application
Jun 13 @ 5:00 pm
DEADLINE: U.S. Tobacco Control Policies to Reduce Health Disparities Application

This National Cancer Institute funding supports research focused on reducing health disparities in tobacco use by developing innovative tobacco prevention and control policies. The long-term goal of this FOA is to reduce health disparities in health outcomes in vulnerable populations by reducing diseases related to tobacco use within these groups. Budgets are not limited but must reflect the amount needed to fund the project.

Click Here to Learn More